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ABSTRACT 
Antibodies to saline extractable nuclear antigens (ENAs) are 
characteristic of certain autoiiranune diseases. The most abundant 
of ENAs are the ribonucleoprotein (RNP) particles. These 
particles reside on small uridine rich RNA called URNA. Sm is 
present on Ul, U2, U4, U5 and U6 snRNPs whereas RNP activity is 
mainly associated with UlsnRNP. Antibodies to Sm are found almost 
exclusively in SLE whereas antibodies to RNP are associated with 
SLE and mixed connective tissue diseases (MCTD). In MCTD, the 
concentration of anti-RNP antibodies are considerably high and 
constitute one of the major criteria for the diagnosis of 
disease. 
In the present study RNP particles were isolated from fresh 
goat liver nuclei by passing the nuclear extract through 
Sepharose 4B and DEAE Sephacel respectively. Gradient 
polyacrylamide gel electrophoresis of RNP particles under 
denaturing conditions showed polypeptides of molecular weight 
29kd, 32kd, 35kd, 40kd, 45kd, 55kd, 65kd, 99kd and ll6kd. The RNP 
particles in presence of hydrogen peroxide were exposed to UV 
light. The hydroxyl radical generated by the combined action of 
ultraviolet light and hydrogen peroxide modified the native 
structure of RNP particles as detected by altered pattern of UV 
spectra and absence of some high molecular weight polypeptides. 
(i) 
The structural modification was also detected by increased 
melting temperature of ROS-RNP (94°C) as compared to native RNP 
particles (86°C). 
Binding of native RNP and ROS-RNP particles with anti-DNA 
positive SLE sera was studied by direct binding and competition 
ELISA. Direct binding studies indicated autoantibody preference 
for ROS-RNP particles. But when native RNP and ROS-RNP particles 
were tested as inhibitors it was found that ROS-RNP particles are 
probably not the preferred antigen for SLE autoantibody binding. 
(ii) 
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The immune system is endowed with potential to discriminate 
between self and nonself and combat with the agents which are 
foreign or nonself (Bicker, 1986). During immunological 
disbalance as a result of internal threat, the body's own tissue 
ccTi^ 'Cnents become reactive and may result in the initiation of 
autoimmune process/disease (Deodhar, 1992) . The earlier 
ccntenticn en spontaneous origin of autoantibodies to many 
nuclear and cytoplasmic antigens in certain human diseases has 
been widely accepted now (Tan, 1989; Pisetsky, 1994) . Those 
diseases which are characterized by the appearance of naturally 
cccuriirg autoantibodies are called autoimmune diseases and 
include systemic lupus erythematosus (SLE), rheumatoid arthritis 
(RA) , Sjogren's S}-ndrome (SS) , Progressive systemic sclerosis 
(PSS) and mixed conr:ective tissue disease (MCTD) . The human SLE 
is characterized by the presence of serum autoantibodies that 
bind to numerous Felf antigens resulting in immune complex 
fcrmetion which subsequently damage endothelial cells and cause 
injury to joints and kidneys. The anti-DNA antibodies derived 
froTT, SLE exhibit multiple antigenic specificities (Ali et al. , 
1£^ 93; Arif et al. , 1994) which include components of DNA and its 
different conformations including modified structures (Hasan et 
al., 1991; Alam and Ali, 1992; Alam et al. , 1995). 
Aetiology of Autoimmune Diseases 
Many theories have been postulated to explain the immune 
response(s) against self components. They include genetic 
factors, exaggerated random B-cell activity, cross reactivity 
between host and foreign antigens or modification of host 
antigens due to infection, drug administration, inflammation 
etc. (Alam et al. , 1993; Ara and Ali, 1993). However the two 
widely accepted opinions regarding immune response against self 
antigens continue to gain support from research in the field of 
general immunology. The opinions state 
(i) that an age dependent breakdown of self tolerance occurs 
i.e. there is less suppression of self reactive 
lymphocytes. 
(ii) that the self reactive antibodies have a true biological 
function, acting as transporting agents for cellular 
breakdown products. 
(iii) an age dependent increase in autoantibodies. 
Ribonucleoprotein (RNP) Particles 
Eukaryotic cells contain a group of metabolically stable 
uridine rich RNAs known as UsnRNAs (Reddy and Busch, 1983; 
Steitz et al. , 1983; Brunei et al. , 1985). In mammalian cells, 
atleast thirteen distinct snRNAs (U1-U13) have been identified 
(Reddy and Montzka et al., 1988). The components U3, U8 and U13 
are localized in the nucleolus where they probably participate in 
pre-rRNA processing events (Kass et al., 1990), while the other 
snRNAs reside in the nucleoplasm. The major nucleoplasmic 
species are Ul, U2, U4, U5 and U6 as shown by indirect 
immunofluorescence using specific antibodies directed against 
these RNPs (Lerner et al., 1980). These snRNAo range in size 
from 95 (U6) to 196 (U2) nucleotides, while UlsnRNA consists of 
171 nucleotides. ihe snRNAs are associated with a set of 
proteins to form ribonucleoprotein particles (snRNPs) (Lerner 
et al. , 1979). The snRNPs have been the focus of scientific 
interest mainly for two reasons. Namely their connection to 
certain autoimmune diseases and the important role which snRNPs 
play in the processing of nuclear pre-mRNAs (Luhrmann et al. , 
1990). These snRNPs are saline extractable nuclear antigens 
(ENA), the most abundant ENA being the Sm and RNP antigens. Sm is 
present on Ul, U2, U4, U5 and U6 snRNPs whereas RNP activity is 
associated with UlsnRNP. 
Antibodies to saline extractable nuclear antigens are of 
considerable interest because their level may go to 20% of the 
total serum immunoglobulins in some disease(s) (Maddison and 
Reichlin, 1977). Such antibodies are found with high frequency 
in patients with rheumatic diseases. So far anti-Sm antibodies 
have been detected in SLE (Conner et al., 1982; Fisher et al., 
1983), anti-Scl 70 in diffuse scleroderma (Jarzabek-Chorzelslca 
et al., 1986), anti UlRNP in SLE and MCTD (Conner et al., 1982; 
Fisher et al., 1983), anti Ro/SSA and anti La/SSB in SLE and in 
Sjogren's syndrome respectively (Lerner et al. , 1981; Reddy et 
al., 1983; Harmon et al. , 1984; Yamagata et al. , 1984; Chan et 
al., 1986) . 
The Sm and RNP are the two most common ribonucleoprotein 
antigens (Tan and Kunkel 1966; Mattioli and Reichlin, 1971; 
Sharp et al. , 197::') which differ in their physico-chemical 
characteristics such as temperature, pH lability and their 
differential sensitivity to RNase. RNP ir sensitive and Sm is 
resistant to RNase (Mattioli and Reichlin, 3 971; Ishaq and Ali, 
1983a). The Sm and RNP antigens have also been differentiated and 
characterized on the basis of the type and number of their 
polypeptides (Hinterberger et al., 1983; Ishaq and Ali, 1983b; 
Steitz et al., 1983). Antibodies to Sm are found almost 
exclusively in SLE whereas antibodies to RNP are associated 
with SLE and MCTD (Tan, 1989; van Venrooij et al., 1989; Luis et 
al., 1992). In MCTD, the concentration of anti-RNP antibodies are 
considerably high and constitute one of the major criteria for 
the diagnosis of MCTD. 
The Sm and RNP antigens can be distinguished by anti-Sm and 
anti-RNP sera. Douvas et al.,(1979) have reported two 
polypeptides of RNP with molecular weight of 13kd and 30kd. 
Lerner and Steitz (1979) reported seven polypeptides of molecular 
weight 12kd to 35kd for both Sm and RNP, while White and Hoch 
(1981) have recognized a 13kd protein as Sm whereas 70 and 40kd 
polypeptides are associated with RNP activity. Philip et al., 
(1982) reported that 70kd and 13kd proteins are conserved across 
species line and suggested that the 40kd and 30kd bands are 
infact degradation products of the VOkd proteins. The 70kd RNP 
antigens contain two mixed charged amino acid clusters of 
approximately 80 and 30 amino acid long which are particularly 
rich in serine, arginine, lysine, glutamic acid and aspartic acid 
residues. Recently it has been reported that the basic amino 
acids predominate in the sequential autoantigenic determinants of 
the 70kd RNP molecule (James et al. , 1994). Sm snRNP is 
composed of a single snRNA and a number of unique and common 
proteins (van Venrooij et al., 1989; Luhrmann, 1990). Sm 
snRNP polypeptides can be divided into three classes according to 
their amino acid sequence and length. 
(i) One type is Sm-B /B which is 240 amino acids long, and 
have a predicted molecular weight of 24.6 kd. The deduced 
amino acid sequence is rich in proline (20%) and glycine 
(15%) (Schmauss et al., 1989). 
(ii) Another class is constituted by the Sm-B polypeptide which 
is 240 amino acids long and have a 93% identity with the 
Sm-s'/B (van Dam et al. , 1989). 
(iii) The third class is constituted by the Sm-B polypeptide 
which is 231 residues long with molecular weight of 23.7 
kd (van Dam et al., 1989). 
There are two major Ro proteins of 60kd and 52kd which are 
acidic in nature. The human 60kd Ro protein is associated with 
four distinct uridine rich RNAs ranging in size from 80 to 112 
nucleotides (Wolin et al. , 1984). Moreover, the human 52kd Ro 
molecule is antigenically and structurally different from the 
60kd molecule (Ben-Chetrit et al. , 1988). La antigen is a 50kd 
phosphoprotein found principally in cell nucleus. It is 
associated with cellular RNAs. Binding of RNA to La depends on 
presence of uridylate residues at the 3' end (Mathews and 
Francoeur, 1984; Stephano et al., 1984) . The function of La 
is to facilitate the termination of transcription of RNA 
polymerase III (Gottlieb et al., 1989). 
Autoantibodies to soluble cellular protein antigens, Ro 
ribonucleoprotein particle (Ro/SSA) have been found primarily in 
Sjogren's syndrome (SS), systemic lupus erythematosus (SLE) and 
in subset of lupus patients (Harley et al. , 1986; Tan, 1989). 
Anti-Ro antibodies have been found in various percentages of 
sera from patients with SLE (12-69%), SS (38-96%), rheumatoid 
arthritis (15-28%) (Tan, 1989; Slobbe et al. , 1991). 
Autoantibodies against SS-B ribonucleoprotein (SS-B/La) antigen 
have been detected in sera of patients with primary Sjogren's 
syndrome, systemic lupus erythematosus, rheumatoid arthritis and 
undifferentiated connective tissue diseases (Akizuki et al., 
1977; Pfeifle et al., 1986). Ro/SSA is found within cytoplasm 
whereas La/SSB has been thought to reside m the nucleus but 
leaks out during preparation of cell fractions (Clark et al , 
1968, Akizuki et al. , 1977) Ro/SSA antibodies have been 
closely associated with the appearance of nephritis, 
vasculitis, lymphadenopathy and leukopenia m SLE patients 
(Maddison and Reichlm, 1976; Alexander et al., 1983). 
Biological Functions of RNP Particles 
Many eukaryotic genes which encode mRNA are separated by 
mtrons Expression of these genes requires the excision of 
mtrons from the primary transcript called pre-mRNA splicing 
They are not self splicing but require the action of 
specialized RNA-protem complex called RNP complex In 
UsnRNPs, Ul, U2 and U4/U6 snRNPs are essential splicing 
factors (Kramer et al , 1984; Black et al. , 1985, Berget, 
1986) The UlsnRNA has a sequence complementary to sequence 
near the 5 splicing site of the nuclear mRNA mtrons and the 
UlsnRNP binds to this region m the primary transcript (Lerner 
et al , 1980) . U2snRNP binds to the branch point of the 
mtrons U4/U6 and USsnRNPs are assembled into the spliceosome 
and interact with pre-mRNA bound Ul and U2snRNPs rather than 
interacting pre-mRNA sequence directly (Bmdereif et al , 1986) 
Reactive Oxygen Species in Relation to Biology and Medicine 
The term reactive oxygen species (ROS) is a collective one 
that includes not only oxygen centred radicals such as 
superoxide anion (0^ ~) and hydroxyl radical (OH'), but also some 
non-radical derivative of oxygen, such as hydrogen peroxide 
(H2O2), singlet oxygen, hypochi .^us acid (HOCl) and ozone (O3). 
Hydroxyl radical is produced in living organisms by at least two 
mechanisms - reaction of transition metal ions with H2O2 and 
homolytic fission of water due to background exposure to 
ionizing radiation (von Sonntage, 1987). Hydroxyl radical is an 
extremely reactive species that can attack all biological 
molecules usually setting off free radical chain reactions 
(Halliwell and Gutteridge, 1989) . Superoxide radical (O2) is 
much less reactive than hydroxyl radical, but a number of 
biological targets can be attacked by it. Superoxide anion can 
act as a vasoconstricter and this may have deleterious effects 
under some clinical conditions (Laurindo et al., 1991). 
Superoxide may inactivate the NADH dehydrogenase complex of the 
mitochondrial electron transport chain (Zhang et al., 1990). 
Some of the superoxide anion production that occur in vivo 
appears to be due to autooxidation reaction and leakage of 
electrons from electron transport chain (Fridovich, 1989; Imlay 
and Fridovich, 1991). 
Hydrogen peroxide is a normal metabolite in aerobic cells 
formed by reduction of dioxygen or by dismutation of the 
superoxide anion radical (Tachon, 1989). In steady state, the 
concentrations of hydrogen peroxide is in the range of lO'^M to 
IC M (Oshmo, 1973). Hydrogen peroxide is a relatively stable 
oxidant and does not cause macromolecule damage by itself. In 
intact cells it is the precursor of a much more damaging 
reactant (Repine et al. , 1981). This very reactant may be the 
hydroxyl radical. However, its production can be increased 
under several pathological conditions, especially at the site of 
inflammation where the oxidative burst of the phagocytic cells 
occur (Hammers and Roos, 1985) and upon irradiation with near 
ultraviolet or visible light (Hoffman and Meneghine, 1979) and 
ionizing radiations (Hart, 1972) . Hydrogen peroxidee crosses 
cell membranes easily and it can attack, apparently directly, a 
few cellular targets. 
Several transition metal salts react with H2O2 to form 
hydroxyl radical. The chemical process that produces it can be 
expressed as the Haber-Weiss reaction (1934). 
H202+0~- OH*+0H" +O2 
The above reaction catalyzed in the presence of iron is known 
as Fenton reaction (1893). 
Fg^2 + H2O2 Fg^^ + OH- + OH" 
0^" + H2O2 OH- + 0H~ + 0 2 
10 
Reactive oxygen species are known to damage a variety of 
biological macromolecules and have been implicated in the 
initiation of many human diseases (Halliwell and Gutteridge, 
1990) . In chronic inflammatory diseases, such as rheumatoid 
arthritis and SLE, the phagocytic cells release reactive oxygen 
species into extra cellular environm.ent which may penetrate cell 
membrane and r^act with DNA (Stollar, 1981; Allan, 1988). 
Subsequent release of this altered DNA may act as an immunogen 
against which anti-DNA antibodies may be generated. ROS modified 
DNA has been proposed as better antigen for SLE anti-DNA 
antibodies (Blount et al. , 1989; Blount et al. , 1990). The ROS 
modified DNA have induced anti-DNA antibody response with 
properties exhibited by anti-DNA autoantibodies (Ara and Ali, 
1992; Alam et al., 1993) . 
Antioxidants and Hydroxyl Radical 
Reactive oxygen species can attack and irreversibly damage 
a diverse spectrum of biomolecules including proteins, nucleic 
acids, phospholipids and sugars. Aerobic organisms have potent 
antioxidant defences to minimize the cytotoxic effects of 
reactive oxidants. Superoxide dismutase (SOD) inactivates 0;^ "^, 
catalase, glutathione peroxidase takes care of hydrogen peroxide 
(Fridovich, 1978; Halliwell and Gutteridge, 1986) . The cells 
also possess non-enz^Tnatic antioxidant mechanisms for scavenging 
hydroxyl radical. Some of these scavengers are in the 
11 
hydrophilic phase (ascorbate, urate, glutathione) and others in 
the lipid phase (o(.-tocopherol, ft-carotene) . Lidocaine, a local 
anaesthetic has been found to be a potent scavenger of hydroxyl 
radicals and singlet oxygen (Das and Misra , 1992). It has been 
widely accepted that oxygen toxicity is normally held in check 
by a balance between the rate of formation and destruction of 
reactive forms of oxygen (Fridovich, 1977). 
Protein Damage by Reactive Oxygen Species 
The free radical damage to proteins consist broadly of 
modification of amino acid residue side chain cross linking and 
fragmentation. The radiation studies indicate that certain 
amino acids were more susceptible than others, these being the 
aromatic amino acids and cysteine. Hydroxyl radicals will attack 
protein molecules almost non-specifically with some preference 
for the aromatic amino acids and cytosine. Hydroxyl radical 
formation is most likely to be catalysed by interaction of H2O2 
with a transition metal ion bound to some specific site on the 
protein and will damage amino acid residues at or near the 
metal binding site (Stadtman et al. , 1991). Modification of 
amino acid residue includes deamination, carbonyl formation, 
oxidation of methionine to its oxide. Carbonyl formation has 
been extensively studied by Stadtman (1990) . Examples of residue 
modifications include conversion of proline and histidine 
residues to glutamate and aspartate respectively (Dean et al. , 
12 
1989) . One of the major types of free radical damage to 
protein is cleavage of peptide bonds and fragmentation of the 
polypeptide chains. Hydroxyl radical can fragment and cress 
link proteins (Schuessler et al., 1984). In the absence of 
molecular oxygen, hydroxyl radical induces cross links in 
protein which are often resistant to reduction. 
The modification of amino acid residues will affect the 
general properties of the protein such as change in charge, 
hydrophobicity and conformations. These changes can lead to 
even aggregations of the molecule (Davies et al., 1987). 
Nucleic Acid Damage by Reactive Oxygen Species 
Hydroxyl radical mediated damage to nucleic acids is well 
aocumented (Rhaese and Frees, 1968; Schweitz, 1969; McDonald et 
al., 1993). It has been suggested that H2O2 mediated DNA damage 
occurs at the metal binding site (Czapski, 1984) . Hydroxyl 
radical may attack DNA at either sugar or base (Hutchinson, 
1985) causing strand breaks and modifications of DNA 
components. Free radicals have also been reported to aid in 
DNA-protein cross-linking between thymine and tyrosine (Olinski 
et al. , 1992) and cytosine and tyrosine (Dizdaroglu et al. , 
1991). Apart from causing base damage in DNA, hydroxyl radicals 
also react with deoxyribose sugar moiety of the nucleic acids 
(Zhao and Jung, 1994). The mechanism of single strand break 
13 
involves addition of OH" across -C=C- double bond of the base or 
abstraction of H atom from sugar (Schulte et al., 1985). Other 
hydroxy 1 damaged product include pyrimidine cyclobutane type 
dimers (Sage, 1993). Numerous assc 'S exist for quantification cf 
free radical mediated DNA damage (Hageman et al., 1992). DNA 
damage of thymine dimers type has been detected by monoclonal 
antibodies (Mizeuno et al., 1991; Potten et al., 1993). 
Objectives of the Present Study 
The main objective of the present work was to study the 
effect of hydroxyl modification on the antigenic property of RNP 
particles binding to autoantibodies derived from SLE sera. The 
RNP antigen was mixed with hydrogen peroxide and exposed to UV 
light of 254 nm. The hydroxyl modified antigen was characterized 
by UV spectroscopy and thermal denaturation studies. The role of 
hydroxyl modified RNP in the pathogenesis of SLE has been 
discussed. 
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A. Materials 
1. Chemicals 
Calf thymus DNA, bovine serum albumin, coomassie brilliant 
blue R 250, agarose, ethidium bromide, anti-human IgG alkaline 
phosphatase conjugate, Phenyl methyl-sulfonyl fluoride (PMSF), 
polyvinyl sulphate (PVS), orcinol, spermine and spermidine were 
purchased from Sigma Chemicals, USA. Ethylene glycol bis (B-amino 
ethyl ether)-N, N, N', N'-tetraacetic acid (EGTA) was purchased 
from Koch-light laboratories, England. Polystyrene flat bottom 
ELISA plates (96 wells) were obtained from NUNC, Denmark. Acryla-
amide, bisacrylamide, N, N, N , N - tetramethyl ethylenediamine, 
Tween-20, ammonium persulphate were obtained from Bio-Rad, USA. 
r'ara-nitrophenyl phosphate was a product of CSIR Centre for Bio-
chemicals, Delhi. Sepharose 4B, Blue dextran 2000, Sephadex G-
200, Ficoll-400 and DEAE Sephacel were obtained from Pharmacia 
Fine Chemicals, Sweden. Nonidet P-40 was from BDH, England. 
Silver nitrate was from Glaxo, Bombay. RNA was isolated from 
buffalo thvTnus. All other chemicals used were of highest grade 
available. 
2. Equipments 
uv -Visible 240 recording spectrophotom.eter (Shiraadzu,Japan) 
m.icroplate reader (MR 600) (Dynatech USA), horizontal electa 
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phoresis assembly (Pharmacia, Sweden), vertical electrophoresis 
apparatus (Bio-Rad, USA.), Fluorescent table and UV lamp of 254 
nm wavelength (Vilber-Lourmat, France), pH meter (ELICO, India) 
were the major equipments used in the present study. 
3 . Servun samples 
Normal human sera were obtained from healthy subjects. 
Sera of patients with systemic lupus e^^ythematosus (SLE) and 
other autoimmune diseases were obtained from outdoor and indoor 
patients of the Department of Medicine, All India Institute of 
Medical Sciences, New Delhi and J.N. Medical College, A.M.U. 
Aligarh. All sera were stored at -20°C with 0.1 percent sodium 
azide as preservative until examined. Serum samples were 
decomplemented before use by heating at 56°C for 30 min. 
4. Organ 
Fresh goat liver obtained from slaughter house was 
immediately frozen in ice-sodium chloride mixture and 
transported to the laboratory. 
B. Methods 
1. Determination of Protein Concentration 
Protein was estimated by the method of Lowry et al. 
(19^ .1) as described below. 
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a. Folin-Ciocalteau Reagent 
The reagent was purchased from CSIR Centre for Biochemicals, 
Delhi and diluted 1:4 with distilled water before use. 
b. Alkaline Copper Reagent 
The constituents of alkaline copper reagent were as 
follows: 
1. 2% sodium carbonate in 0.1 N NaOH 
11. 0.5% copper sulphate in 1% sodium-potassium tartarate 
The working reagent was prepared hy mixing 50 ml of (i) 
with 1 ml of (ii) and used immediately. 
c. Procedure 
One ml of protein sample in appropriate buffer was mixed 
with 5.0 ml of alkaline copper reagent and kept at room 
temperature for 10 min. At the end of incubation one ml of 
Folm Ciocalteau reagent was added and the contents were 
further incubated for 30 mm. The absorbance of developed colour 
was read at 660 nm. Protein content of the unknown samples were 
computed from the standard plot drawn using different 
concentration of bovine serum albumin (Fig 1). 
2. Determination of DNA concentration 
Colorimetric estimation of DNA was carried out by the method 
of Burton (1956) using diphenylamme reagent. 
17 
40 60 80 100 
Amount of B5A (jag /ml) 
Fig Standard plot for the colorimetric estiiration 
of protein. 
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a. Diphenylamine reagent 
To 750 mg of diphenylamine was added 50 ml of glacial 
acetic acid followed by 0.75 ml of concentrated sulphuric acid. 
The reagent was prepared immediately before use. 
b. Procedure 
One milliliter DNA sample was mixed with 1 ml of IN 
perchloric acid and tubes were kept at 70°C for 15 min in a 
thermostat water bath. Then 0.1 ml of 5.43 mM acetaldehyde was 
added followed by 2 ml of diphenylamine reagent. The contents 
were mixed and allowed to stand at room temperature for 16-20 
hours. The developed colour was read at 600 nm. The DNA 
concentration in unknown sample was determined from standard 
plot of calf thymus DNA (Fig. 2). 
3. Determination of RNA concentration 
RNA was estimated by ferric ion catalysed orcinol 
reaction (Ceriotti, 1955). 
a. Crystallization of Orcinol 
Five gm of commercial orcinol was dissolved in 100 ml 
boiling benzene and decolorized with 1 gm of activated animal 
charcoal. The suspension was filtered while hot and kept at 
room temperature for 1 hour and then at 4°C until the 
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crystallization was complete. The crystals were separated by 
filtration and dried at room temperature. 
b. Orcinol reagent 
i. 100 mg ferric chloride was dissolved in 100 ml concentrated 
HCl 
ii. 6% (w/v) orcinol in distilled ethanol 
The reagent was prepared fresh by mixing 3.5 ml of (ii) 
with 100 ml of (i) and used immediately. 
c, Procedure 
Two milliliter of RNA solution was mixed with 3 ml of 
orcinol reagent and placed in boiling water for 30 min. The 
tubes were chilled in ice water and absorbance was measured at 
665 nm. RNA concentration of unknown samples were calculated 
from the standard plot of buffalo thymus RNA (Fig.3). 
4. Isolation of Immunoglobulin G (IgG) 
Serum IgG was isolated by ion exchange chromatography 
and purified on Sephadex G-200 column. 
a. Preparation of crude immunoglobulins 
To 6.5 ml of decomplemented serum was added dropwise 
saturated ammonium sulphate solution allowing each drop to 
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disperse before the next was added. When the concentration of 
ammonium sulphate reached about 20% of saturation the serum 
had begun to turn milky. Most immunoglobulins got precipitated 
by 35-37% of saturation. The reaction was carried out at 4°C. 
The suspension was stirred for 30 min and then centrifuged 
at 10,000 rpm for 15 min. The pellets thus obtained was washed 
two or three times in 35% saturated ammonium sulphate. 
Repeated washing of the pellet considerably reduced 
contamination with non-immunoglobulin proteins and did not lower 
the yield significantly. Finally the precipitate was dissolved 
in phosphate buffered saline (PBS, pH 8.0). Ammonium sulphate 
was removed by overnight dialysis against 500-1000 volumes of 
0.0175 M sodium phosphate buffer, pH 6.8. 
b. DEAE Sephacel ion exchange chromatography 
Dialysed crude immunoglobulins were loaded on the top of a 
column of DEAE Sephacel (20 cm x 1.5 cm) previously equilibrated 
with the same buffer. The column was eluted with 0.0175 M 
sodium phosphate buffer, pH 6.8. Fractions of 3.0 ml were 
collected and monitored for protien content at 280 nm, assuming 
1.4 O.D.28Q = 1 mg/ml IgG. 
The first peak of the chromatogram was found to contain 
IgG (Fig. 4) . The homogeneity of isolated IgG was checked by 
single band movement in SDS-PAGE. 
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c. Isolation of IgG by gel filteration method 
Crude immunoglobulins were loaded on a gravity packed 
Sephadex G-200 column (75 cm x 2 cm) previously equilibrated 
with 0.0175 M sodium phosphate buffer, pH 6.8. The column was 
operated at a flow rate of 25 ml/hour and fractionated 
immunoglobulins were monitored for protein at 280 nm. The IgG 
peak was identified by absorbance measurements at 278 and 251 nm. 
Mammalian IgG absorbance at 278 nm is about 2.5 to 3.0 times 
higher than at 251 nm, in contrast to other serum proteins 
where this ratio is about 1-1.5 (in neutral buffers). (Fig. 5). 
5. Polyacrylamide Gel Electrophoresis (PAGE) 
The purity of isolated IgG was checked through 
polyacrylamide slab gel electrophoresis under denaturing 
conditions as described by Laeramli (1970). 
i. Stock Solutions 
a. Acrylamide - bisacrylamide (30:0.8) 
The stock solution was prepared by dissolving 30 gm 
acrylamide and 0.8 gm bisacrylamide in a total volume of 100 ml. 
As far as possible , the mixture was protected from light. 
b. Resolving gel buffer, 3 M Tris-HCl 
Stock solution of buffer was prepared by dissolving 36.3 gm 
Tris in 48.0 ml of IN HCl. The contents were mixed thoroughly, 
pH adjusted to 8.8 and volume brought to 100 ml. 
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c. Stacking gel buffer, 0.5 M Tris-HCl 
6.05 gm Tris was dissolved in 40 ml of distilled water, 
titrated to pH 6.8 with IN HCl (-48 ml) and volume adjusted to 
100 ml with distilled water. 
ii. Electrode buffer 
0.025 M Tris and 0.192 M glycine,pH 8.3 containing 0.1% SDS 
iii. Sample buffer 
a. Six gm Tris was dissolved in 80 ml distilled water and pH 
adjusted to 6.8 with phosphoric acid . The volume was made 
to 100 ml with distilled water. 
b. To 12.5 ml of above sample buffer, was added 1 mg 
bromophenol blue and 12.5 ml glycerol. One part of (b) and 
four part of sample were mixed and boiled for five min. 
prior to loading. 
iv. Procedure 
Glass plates separated by spacer of appropriate thickness 
were sealed with agarose dissolved in resolving gel buffer. The 
polymerizing mixture was poured between the glass plates and 
left at room temperature for complete polymerization. Protein 
samples were prepared and loaded in wells. The gel was run 
for 8-10 hours at 80 volts. At the end of electrophoresis the 
gel was stained with coomassie brilliant blue dye. 
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RECIPE FOR 7.5% SDS-PAGE 
(Total volvune 4 0 . 0 ml) 
Acrylamide - bisacrylamide 
Resolving gel buffer 
10% SDS 
1.5% Ammonium persulphate 
Distilled water 
TEMED 
10.0 ml 
5.0 ml 
0.4 ml 
2.0 ml 
22.6 ml 
0.02 ml 
Acrylamide-bisacrylamide 
Resolving gel buffer 
10 % SDS 
1.5 % Ammonium persulphate 
Distilled water 
TEMED 
RECIPE FOR 5-20 % GRADIENT GEL 
(Total volume 24.0 ml) 
5 % gel 
2.0 ml 
1.5 ml 
0.1 ml 
0.6 ml 
7.774 ml 
0.006 ml 
20 % gel 
8.0 ml 
1.5 ml 
0.1 ml 
0.6 ml 
1.774 ml 
0.006 ml 
6. Isolation and Purification of Ribonuleoprotein (RNP) Antigens 
Ribonucleoprotein antigen was isolated from goat liver 
nuclei. All procedures were carried out at 0-4°C. Acid washed 
glassware and sterilized rolutions were used to prevent 
nuclease and protease activity. 
Homogenizing medivun 
Homogenizing u'ledium (HM) contained 250 mM sucrose 5 mM 
magnesium acetate, 0.1 mM ethylene glycol bis (p-amino ethyl 
ether'-N, N,N'N'-tetraacetic acid (EGTA) and 5 mM 2-
mercaptoethanol. In addition , it contained 1 mM phenyl methyl 
sulphonyl fluoride (PMSF) , 1 mM spermine, 1 mlA spermidine and 
10 pg/ml polyvinyl sulphate (PVS). PMSF was dissolved in 
minimal volume of isopropyl alcohol and then added to HM 
immediately before use. HM-NP40 contained all the above 
components plus 0.5 percent (v/v) Nonidet P-40. 
a. Isolation of nuclei 
Nuclei were isolated essentially by the method of Douvas et 
al (1979) with slight modifications. Briefly frozen liver 
was thawed in HM for 20-30 m.in. The thawed tissue was cut into 
small pieces and homogenized with chilled HM for short period 
to avoid nuclear breakdown. The homogenate was filtered 
througn 3-4 layers of cheese cloth. The filtrate was 
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centrifuged at 2500-3000 rpm for 10 min. The pellets were washed 
twice and extracted with HM-NP40 for 30 min. using magnetic 
stirrer. The suspension was centrifuged and the pellets were 
washed thrice with riM-NP40. The final washing of the pellets 
were performed with HM. 
b. Extraction of nuclei 
Nuclear pellets were extracted four times with STM buffer 
(10 mI-1 Tris-HCl, 100 niM KaCi, 1 vM MgCl2 containing 1 mM PMSF 
and 10 ug/ml polyvinyl sulphate, pH 8.0). Each extraction (end 
to end) was carried out for 1-2 hours. The insoluble material 
was separated by centrifugation and supernates pooled together 
and dialysed against STM buffer to remove sucrose. The 
insoluble material formed during dialysis was centrifuged out 
and the supernatant designated as nuclear extract was used as 
the source of ribonucleoprotein (KNP) antigens. 
c. Sepharose 4E chromatography 
The nuclear extract was passed through a column of Sepharose 
4B (70 cm X 2 cm) earlier equilibrated with STM buffer. Elution 
was carried out with STM buffer. Fractions of 3 ml were 
collected and monitored for protein, R1\'A and DNA contents. The 
fractions containing protein were pooled and dialysed against 
10 mM sodium phosphate buffer pH 7.3 containing 50 mM NaCl. 
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d. DEAE Sephacel chromatography 
The dialysed antigen was loaded onto a column of DEAE 
Sephacel (6 cm x 1.5 cm) washed and equilibrated with 10 mM 
sodium phosphate buffer, pH 7.3 containing 50 mM NaCl. The 
ribonucleoprotein antigens were eluted with 10 mM sodium 
phosphate buffer, pH 7.3 containing 300 mM NaCl. 
7. Irradiation of Ribonucleoprotein (RNP) Antigens 
Ribonucleoprotein antigen (0.00145 mM) in PBS (0.01 M sodium' 
phosphate buffer containing 0.15 M NaCl, pH 7.4) were irradiated 
under 254 nm UV light for 30 minutes at room temperature in 
presence of hydrogen peroxide. The molar ratio of RNP to 
hydrogen peroxide was 1:100. RNP exposed to UV light in the 
absence of hydrogen peroxide served as control. RNP - hydrogen 
peroxide complex was also included as internal control. 
8. Thermal Denaturation of RNP Antigens 
Melting curves of unmodified and modified ribonucleoprotein 
antigen was recorded on spectrophotometer equipped with melting 
device as described earlier (Hasan and Ali, 1990). Samples were 
melted from 30°C to 95°C at a rate of 1.5°C per min. The 
wavelength was fixed at 280 nm. Percent denaturation was 
calculated as follows 
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( A^ - A^o ) at various temperature 
Percent denaturation = x 100 
( A^ - A3Q ) at 95°C 
Where, A = absorbance value at a particular temperature 
A3Q = absorbance value at 30°C. 
9. SDS-PAGE of Ribonucleoprotein (RNP) Antigens 
The RNP antigens were dialysed against 20 mM Tris-HCl (pH 
7.4) buffer containing 2 mM EDTA, 5 mM 2- mercaptoethanol, 0.1% 
SDS and electrophoresed on 5-20% gradient gel. The gel 
mixture was poured between the plates and allowed to polymerize 
at room temperature. Two hundred microgram RNP antigen was loaded 
and run for 8-10 hrs at 80 volts at room temperature. At the 
end of electrophoresis the gel was stained with coomassie 
brilliant blue R250 (0.25% in 10% acetic acid and 25% methanol). 
The visible bands were photographed and recorded. 
10. Agarose Gel Electrophoresis of RNP Antigens 
Agarose was dissolved at a concentration of 0.4% in 
electrophoresis buffer (40 mM Tris-acetate, pH 8.0 containing 
2 mM EDTA) and poured in tray fitted with combs. RNP antigens 
were loaded in the wells and electrophoresed for 2-4 hours at 
3 0 mA. At the end of process the gel was stained in ethidium 
bromide and visualised for RNA under UV light. 
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11. Direct Binding ELISA 
The following reagents were prepared in distilled water and 
used in enzyme immunoassay. 
a. Tris buffered saline (TBS) 
10 mM Tris, 150 mM NaCl, pH 7.4 containing 0.02% sodium 
azide as preservative. 
b. Tris buffered saline - Tween 20 (TBS-T) 
20 mM Tris, 144 mM NaCl, 2.68 mM KCl pH 7.4 containing 
500 ^1 Tween-20 in one litre. 
c. Bicarbonate buffer 
15 mM sodium carbonate, 35 mM sodium bicarbonate and 2 mM 
magnesium chloride, pH 9.6 containing 0.02% sodium azide as 
preservative. 
d. Substrate 
500 pg para-nitrophenyl phosphate in 1 ml bicarbonate 
buffer. 
Procedure 
SLE autoantibody binding to DNA, RNP and ROS-RNP in SLE 
were detected by ELISA. Anti-DNA antibody, were detected on 
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microtiter wells previously coated with 100 ul of poly D-lysine 
(50 pg/ml in distilled water) for 30 min at room temperature. The 
plate was washed thrice with TBS and coated with 100 }il of DNA 
(2.5 pg/ml in TBS) for 2 hours at room temperature and overnight 
at 4°C. The antigen coated wells were washed thrice with TBS-T 
to remove the unbound antigen and 100 jal/well of poly-L-
glutamate (50 >ig/ml in TBS) was coated for 2 hours at room 
temperature. In case of RNP antigen the wells were coated with 
100 ul of stock (40 pg/ml in carbonate - bicarbonate buffer) and 
incubated for desired time period. The plates were washed thrice 
with TBS-T and the unoccupied sites were blocked with 150 jul 
of BSA (1.5% in TBS) for six hours at room temperature. The 
plates were washed once with TBS-T and serially diluted SLE sera 
were added to wells. After incubation for 2 hours at room 
temperature and overnight at 4°C. The bound antibodies were 
assayed by anti-human IgG alkaline phosphatase conjugate using 
para-nitrophenyl phosphate (PNPP) as colorigenic substrate. The 
plates were developed for 45-60 min and reaction was stopped by 
adding 100 ul of 3 M NaOH solution in each well. The absorbance 
of each well was monitored at 410 nm. Results were expressed 
as a mean of A^^^^- A^^^^^Q^. 
12. Inhibition ELISA 
Antibody specificity was determined by inhibition 
experiments (Alam et al. , 1993, 1995). Briefly varying amount 
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of inhibitors were mixed with a constant amount of antibody and 
mixture was incubated for 2 hours at room temperature and 
overnight at 4°C. The immune complex thus formed was coated on 
to the wells instead of serum. The remaining steps were same 
as described earlier. 
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The most striking feature of human SLE is the presence of 
circulating antibodies against nDNA (B-conformation). Their level 
is a direct measure of the disease state. Since immunization with 
mammalian nDNA have failed to induce anti-DNA antibodies beyond 
adjuvant level, it has been postulated that DNA modified by 
physical/chemical/environmental agents is the likely immunogen. 
Some other structurally altered macromolecule is the stimulus for 
the production of characteristic autoantibodies to cellular and 
nuclear components. Among the highly conserved cell components 
that can be target of the autoimmune reactions are the 
ribonucleoprotein (RNP) particles. Under oxidative stress these 
particles might behave as immunogenic trigger for the 
production of at least a sub-population of SLE autoantibodies 
while DNA is actually a crossreacting antigen. 
Purification and Characterization of Ribonucleoprotein Particles 
The goat liver nuclei was chosen as the source of 
ribonucleoprotein particles in view of its easy availability in 
bulk besides being a rich source of RNP particles. Isolated 
nuclei were extracted with STM buffer and nuclear extract was 
subjected to protein and nucleic acids determinations. Protein, 
RNA and DNA content of the nuclear extract was found to be 21, 
36 and 33.2 percent respectively. 
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Nuclear extract passed through Sepharose 4B column 
separated into two peaks (Fig 6) . Colorimetric estimation of 
peak fractions by orcinol reagent revealed 22.8 pg/ml and 13 
pg/ml RNA in peak 1 and peak 2 respectively. Fraction of peak 1 
and peak 2 were concentrated separately and dialysed against 10 
mM sodium phosphate buffer, pH 7.3 containing 50 rrM NaCl. 
The concentrated sample was passed through DEAE Sephacel column 
and unbound proteins were washed with sodium phosphate buffer. 
The bound protiens were eluted as single peak (Fig. 7). 
Fractions were devoid of DNA. After extensive dialysis against 10 
mM sodium phosphate buffer, pH 7.3 containing 50 mM sodium 
chloride the proteins were analyzed on polyacrylamide gel under 
denaturing conditions. The results shows polypeptide bands in the 
range of 29 kd to 116 kd (Fig. 8). That the RNA quantitated by 
orcinol reagent was indeed contributed by RNP particles (and not 
as contamination) was further confirmed by ethidium bromide 
induced fluorescence of agarose gel (Fig. 9). 
Modification of RNP Particles with Hydroxyl Radical 
The ribonucleoprotein particles were irradiated under 254 
nm UV light for 30 min at room temperature in the presence of 
hydrogen peroxide in the molar ratio of 1:100 (RNP:H202). 
Excess of hydrogen peroxide from the reaction mixture was 
removed by extensive dialysis against PBS, pH 7.4. The UV 
absorption spectra of hydroxyl modified RNP particles alongwith 
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Fig. 6. Elution profile of goat liver nuclear extract passed 
through Sepharose 4B column. Nuclear extract was 
loaded on Sepharose 4B column (70 x 2 cm) 
equilibrated with STM buffer. Three ml fractions were 
collected and monitored at 260 (—O ) and 280 nm 
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Fig. 7 (a) DEAE-Sephacel ion exc.iange 
Sepharose 4B fractionated peak 
chromatography of 
(b) DEAE-Sephacel ion exchange chxomatography of 
Sepharose 4B fractionated peak 2. 
Concentrated sample of peak 1 and peak 2 fractions 
were loaded and eluted with 300 mM NaCl. 
Three ml fractions were collected and monitored at 
260 nm (—O—) and 280 nm 
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Fig. 8. Banding pattern of native RNP protein 
antigens in polyacrylamide gel under 
denaturing conditions. Samples were 
mixed with 10 mM Tris, pH 8.8 containing 
1 percent SDS and 5 percent 2-
mercaptoethanol boiled for 3 min and 
loaded on gradient gel. (a) Peak 2 (b) 
protein marker (c) Peak l 
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Fig. 9. Submarine agarose gel electrophoresis of 
RNP particles, (a) Buffalo thymus RNA 
(b) Peak 1 (c) Peak 2 
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proper controls was recorded to detect changes in the absorption 
pattern. UV absorption profile of native RNP particles showed 
maxima at 270 nm and minima at 255 nm (Fig. 10) . Irradiation of 
RNP particles without hydrogen peroxide showed a shoulder around 
260 nm while the characteristics \ max at 270 nm of native RNF 
was lost (Fig.11). On the other hand, RNP-hydrogen peroxide 
complex not exposed to UV light resulted in almost 35% decrease 
in absorption at 270 nm. Absorption spectrum of RNP-H2O2 complex 
exposed to UV light showed almost 42% decreased in absorbance at 
270 nm. Almost total loss of characteristic maxima was observed 
(Fig. 10). 
Characterization of ROS Modified RNP Particles 
Melting characteristics of modified and unmodified RNP 
particles was monitored between 30°C and 95°C. Increase in 
absorbance at 280 nm was recorded by heating the samples at a 
rate of 1.5°C/min. The Tm values of RNP and ROS-RNP particles was 
found to be 86°C and 94°C respectively (Fig. 12). 
To detect the effect of hydroxyl radical on particle 
proteins, SDS-PAGE of ROS-RNP particles alongwith native RNP 
particles as control was carried out. The native RNP particles 
used as control showed polypeptide of molecular weights of 29Kd 
32Kd, 35Kd, 40Kd, 45Kd, 55Kd, 65Kd, 99Kd and 116Kd. The banding 
pattern of ROS-RNP fractionated proteins, as compared to native 
RNP proteins revealed only five polypeptides of 29Kd, 32kd, 40kd, 
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55kd and 65kd respectively (Fig. 13) . The disappearance of high 
molecular weight polypeptides may be due to their fragmentation 
into smaller peptides which is beyond the detection limit 
(sensitivity) of Coomassie Brilliant Blue R 250. 
Enzyme Immxinoassay 
The binding studies of RNP and ROS-RNP particles with anti-
DNA antibodies positive SLE sera were carried out by direct 
binding and competition immunoassays. Of the 20 suspected SLE 
samples, only six sera were found to have moderate to high 
antibody level and were chosen for further studies. The direct 
binding and competition ELISA results of above samples are shown 
in Fig. 14 and Table 1 respectively. Binding of SLE sera was 
carried out with RNP and ROS-RNP particles coated separately in 
equal amounts on microtiter plates. Binding of SLE 
autoantibodies, at 1:100 dilution, with ROS-RNP particles was 
observed to be higher and of varying degree in Fig. 15. The 
binding specificity of SLE auto-antibodies to RNP and ROS-RNP 
particle was further evaluated by competitive enzyme immunoassay 
on plates coated with native RNP particles. The SLE sera showed 
inhibition of autoantibody binding with RNP and ROS-RNP particles 
used as competitor (Fig. 16). The inhibition data reveals that 
ROS modified RNP particles are not a better competitor for SLE 
autoantibody as the modification has resulted in decreased 
inhibition compared to native RNP particles. 
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Fig. 13. Polyacrylamide gel electrophoresis of 
ROS-RNP particles under denaturing 
conditions. 
Samples were mixed with 10 mM Tris, pH 
8 .8 containing 1 percent SDS and 5 
percent 2-mercaptoethanol boiled for 3 
min and loaded on gradient gel. (a) ROS-
RNP (b) protein marker (c) native RNP. 
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(a) 
(b) 
Direct Binding ELISA of SLE sera 
was coated with native DNA 
(-0—) SLE Serum 1, (-#-) 
SLE Serum 3, (—A—) 
SLE Serum 4, (-0-) 
( # ) SLE Serum 6, 
The plate 
SLE Serum 2 
Negative control 
SLE Serum 5 
Negative control 
48 
TABLE.1 
Competition ELISA of SLE sera showing the inhibition of DNA-anti-
DNA antibodies interaction by native DNA. 
SERA 
NUMBER 
IC5Q (ug/ml) Minimum percent inhibition 
1 
2 
4 . 
5 . 
6 . 
1.6 
3 .0 
4 . 5 
2 0 . 0 
2 2 . 0 
5 0 . 0 
5 8 . 3 
7 0 . 7 4 
7 5 . 4 
5 5 . 4 
5 5 . 6 
5 1 . 0 7 
IC 50 Competitor concentration for 50 percent inhibi t ion. 
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Fig. 15. Direct binding EUSA of SLE sera with native RNP (| 
and ROS-RNP([;;;;^ ). 
Fig. 16 
(a) 
Competition ELISA showing the inhibition of 
various SLE autoantibody activity with native and 
ROS-RNP particles. 
Serum 1: (—O ) native RNP particles, 
ROS-RNP Particles. 
Serum 2:( •• ) native RNP particles, (—A-
Particles. 
ROS-RNP 
Serum 3: (—#— ) native RNP particles, 
ROS-RNP Particles. 
Serum 4: (-»-) native RNP particles, {-A-
Particles. 
ROS-RNP 
(c) Serum 5: (—O—) native RNP particles, ( 
ROS-RNP Particles. 
Serum 6: (—• ) native RNP particles, ( ,4-
ROS-RNP Particles. 
50 
1 5 10 20 40 
Inhibitor concentration { ^g /ml ) 
1 5 10 20 40 
Inhibitor concentration ( >tg/ml) 
1 5 10 20 40 
Inhibitor concentration (jxg/ml) 
tMyuM^xyn 
51 
Systemic lupus erythematosus (SLE) is an autoimmune disease 
of unknown etiology characterized by the presence of antibodies 
to numerous self components which include nuclear and cytoplasmic 
antigens (Tan, 1989; Pisetsky, 1994). Native DNA (B-conformation) 
is a poor immunogen and antibodies are rarely induced upon 
immunization (Madaio et al., 1984). However, a number of 
synthetic polynucleotides and conformational variants of DNA 
including modified structures have been shown to be potent 
immunogen (Hasan et al. , 1991; Alam and Ali, 1992; Alam et al. , 
1995). Earlier studies have suggested that circulating antibodies 
against a variety of cellular components found in patients with 
SLE and mixed connective tissue diseases (MCTD) may serve as 
useful tool for studying structure and function of small 
ribonucleoprotein (snRNP) complex (Lerner and Steitz, 1981). 
Autoantibodies binding to ribonucleoprotein (RNP) particles are 
often found in patient with SLE and SLE overlap syndrome (Tan, 
1989) . 
In recent years there has been considerable interest on 
reactive oxygen species (ROS) and the damage caused to living 
system in their presence (Halliwell, 1987; Yu, 1994). Role of 
ROS in the development of autoimmune diseases, cancer, diabetes 
and other human diseases has been the subject of recent studies 
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(Ames, 1983; Meneghini, 1988; Lunec et al., 1994). Among the 
reactive oxygen intermediates, hydroxyl radical is considered to 
be extremely dangerous species reacting with many biological 
macromolecules in its vicinity. Effect of hydroxyl radical on 
the antigenic structure of nuclear and cytoplasmic protein has 
been thoroughly discussed to suggest their possible role in SLE, 
cancer and other degenerative diseases (Stadtman, 1990; Stadtman 
and Oliver 1991) . The free radical damage to proteins consisted 
mainly crosslinking and fragmentation. In general, aromatic amino 
acids and cysteine residues are more susceptible to free radical 
attack (Grossweiner and Smith, 1989). 
Nuclear extract passed through Sepharose 4B column followed 
by DEAE Sephacel chromatography revealed polypeptide bands of 
29Kd, 32Kd, 35Kd, 40Kd, 45Kd, 55Kd, 65Kd, 99Kd and 116Kd in 
polyacrylamide gel under denaturing conditions. There has been 
considerable variation in the published reports on the molecular 
weight of RNP particles. The demonstration of number of 
polypeptide bands in our case is in close agreement with earlier 
reports on RNP particles isolated from other sources (Lerner and 
Steitz, 1979; White et al. , 1981; Billings et al., 1982). 
Studies from this laboratory have reported the polypeptides of 
molecular weight 14Kd, 30Kd, 70Kd and 80Kd (Ishaq and Ali, 1983). 
The UV absorption profile of native RNP particles showed 
maxima at 270 nm and minima at 255 nm. The RNP-hydrogen peroxide 
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complex, not exposed to UV light, resulted in almost 35% decrease 
in absorbance at 270 nm. Absorption spectra of RNP-hydrogen 
peroxide exposed to UV light of 254 nm showed almost 42% 
decrease in absorbance. The appearance of shoulder at the 
wavelength maxima coupled with decreased absorbance appears to be 
a consequence of hydroxyl radical modifying effect on RNP 
particles. Furthermore, since aromatic amino acids of proteins 
are the major chromophores responsible for UV light absorption, 
the 42% decrease in absorbance value of ROS-RNP could possibly 
be attributed to the modification of RNP particles. Moreover, 
the disappearance of some high molecular weight polypeptides of 
ROS-RNP particles, compared to native RNP particles, appears to 
be due to fragmentation of the pol^ 'peptides by reactive oxygen 
species. And this fragmentation has produced peptides of such 
small molecular weight that they can not be detected on our 
conventional polyacrylamide gel usig Coomassie Brilliant Blue R 
250 as staining dye. 
Thermal denaturation studies of ROS-RNP particles indicated 
melting temperature (Tm) of 94°C. The Tm of native RNP particles 
was found to be 86°C. The increased melting temperature of ROS-
RNP particles may be the result of crosslinking of RNA with 
particle proteins. Studies have shown that RNP particles exposed 
to 254 nm UV irradiation in the presence of hydrogen peroxide 
leads to direct crosslinking of ribonucleoprotein to snRNAs 
(Woppmann et al., 1988). 
54 
Anti-DNA positive SLE sera were selected on the basis of 
specificity with native DNA in competition ELISA. Binding of 
anti-DNA positive sera with native RNP and ROS-RNP particles was 
studied employing direct binding and competitive immunoassay. 
In direct biding assay on ELISA plates coated separately with 
equal amount of native RNP and ROS-RNP the SLE autoantibodies 
were found to show more binding with ROS-RNP particles with each 
samples. Whether this binding was specific is debatable as there 
are many non-specific proteins in serum which could show binding. 
To sustain the results of direct binding assay, competition 
ELISA was performed on ELISA plates coated with RNP particles. 
RNP and ROS-RNP were used as competitor for SLE anti-DNA 
autoantibodies. Result analysis revealed that modification of 
RNP particles by hydroxyl radical has destroyed some of the 
antigenic property of the particles as the extent of inhibition 
with ROS-RNP particles was low compared to native RNP particles. 
The decreased inhibition with ROS-RNP particles could be 
explained as follows : 
1. As a result of crosslinking, some epitopes of RNP particles 
are being masked and therefore not available for antibody 
binding. 
2. There appears to be loss of some particle epitopes as a 
result of hydroxyl attack on aromatic amino acids. 
3. The ROS-modified RNP particles appears not involved in 
disease initiation or progression. 
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